249 related articles for article (PubMed ID: 12267101)
21. The levonorgestrel-releasing intrauterine device.
Toivonen J
Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
[TBL] [Abstract][Full Text] [Related]
22. Fertility regulation technology: status and prospects.
Segal SJ; Nordberg OS
Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study of the Copper T 200 IUD with or without string].
Cohen J
Contracept Fertil Sex (Paris); 1987 Dec; 15(12):1157-60. PubMed ID: 12341738
[TBL] [Abstract][Full Text] [Related]
24. Statement on intrauterine devices (IUDs).
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
[TBL] [Abstract][Full Text] [Related]
25. [Fertility and characteristics of ovulation after discontinuing oral contraception].
Gaspard U; Lambotte R
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of IUDs: an ultrastructural view.
El-badrawi HH; Hafez ES
Contracept Deliv Syst; 1981 Jul; 2(3):201-17. PubMed ID: 12278906
[TBL] [Abstract][Full Text] [Related]
27. [Amenorrhea following the administration of oral contraceptives].
Gertrudis Diez MA
Acta Ginecol (Madr); 1984 Apr; 41(4):201-6. PubMed ID: 12267262
[TBL] [Abstract][Full Text] [Related]
28. Post coital contraception.
Haspels AA; Van Santen MR
J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
[TBL] [Abstract][Full Text] [Related]
29. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
[TBL] [Abstract][Full Text] [Related]
30. [[Measurement of menstrual blood loss following insertion of Copper-V 200 intrauterine device]].
Jing PH; Huang ZL; Liu QX
Shengzhi Yu Biyun; 1982 Sep; 2(3):19-22. PubMed ID: 12312671
[TBL] [Abstract][Full Text] [Related]
31. Effect of clinic related factors on continuation rates of IUDs.
Reading AE; Goldstuck ND
Contracept Deliv Syst; 1982 Jan; 3(1):1-9. PubMed ID: 12264121
[TBL] [Abstract][Full Text] [Related]
32. The influence of high- and low-dose hormonal contraceptives on HDL and total cholesterol levels.
Pretnar Darovec A; Novacan Hudnik S
Acta Reprod Turc; 1987; 8(3-4):37-42. PubMed ID: 12316487
[TBL] [Abstract][Full Text] [Related]
33. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
34. [Intra-uterine contraceptive devices in nulliparous women: a retrospective study].
Cabral AC; Celani MF; Roquette AL
J Bras Ginecol; 1985; 95(6):231-3. PubMed ID: 12267708
[TBL] [Abstract][Full Text] [Related]
35. Hematologic characteristics in IUD users.
Nehra PC; Magyar DM
Contracept Deliv Syst; 1982 Apr; 3(2):149-54. PubMed ID: 12338169
[TBL] [Abstract][Full Text] [Related]
36. Continuous low dose progestagen for contraception.
Martinez-manautou J
IPPF Med Bull; 1968; 2(5):2-3. PubMed ID: 12155573
[TBL] [Abstract][Full Text] [Related]
37. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
Goh TH; Ang ES; Yip YC
J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
[TBL] [Abstract][Full Text] [Related]
38. [Sexually transmitted diseases (STD) in adolescent girls].
Henry-suchet J
Contracept Fertil Sex (Paris); 1987 Apr; 15(4):413-6. PubMed ID: 12315322
[TBL] [Abstract][Full Text] [Related]
39. The vaginal contraceptive pill.
Coutinho E
IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
[TBL] [Abstract][Full Text] [Related]
40. Hysterography and the IUD.
Reiertsen O; Eyjolfsson O
Contracept Deliv Syst; 1980 Oct; 1(4):389-98. PubMed ID: 12262142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
